BridgeMD
Alcohol Use and Behavior in Young Adults
EU CTIS ID: 2022-501809-13-01
What this study is testing
Does oxytocin (compared to placebo) for individuals with high alcohol use increase prosocial behavior?
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 18-24 years of age
- Male
- Give informed consent and comply with study procedure
- High alcohol use individuals: Fulfils criteria for at least moderate AUD the past 12 months according to MINI Neuropsychiatric Interview
- High alcohol use individuals: Fulfils at least 8 points on the Alcohol Use Disorder Identification Test
You likely can't join if
- Fulfils criteria for any substance use disorder (except AUD for High Alcohol-group, and mild cannabis- and nicotine use disorder for both groups).
- History of severe psychiatric disorder (e.g. severe depression, bipolar, antisocial personality disorder) or neuropsychiatric disorder of ADHD, autism or Tourette’s.
- Using intranasal medicine that could not be stopped 48 hours prior to each visit
- Allergy or intolerance to preservatives in nasal spray, e.g. latex allergy.
- Upper-respiratory tract infection (i.e. a ‘common cold’ resulting in significant nasal congestion) at day of testing (but with the possibility of rescheduling for another time point)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.